Rents Rising, Supply Falling — The Investor's Window
The Supply Collapse Is Real — And It's Not Reversing Quickly
Zoopla's March 2026 figures, highlighted by Quartico in April 2026, put rental supply 23% below pre-pandemic levels across the UK. That number deserves a moment. Not a trend line nudging downward. Twenty-three percent.
The mechanism driving this isn't mysterious. Landlords have been exiting. Section 24 tax changes, the incoming Renters' Rights Bill, rising compliance costs on HMO licensing — all of it has accelerated a quiet exodus from the private rented sector. Every landlord who sells up and exits takes supply with them. And that supply doesn't come back quickly, because the economics of building new rental stock at scale in the UK remain brutal.
This is the part that most commentary gets wrong. People frame the supply drop as a temporary dislocation. It isn't. The regulatory headwinds that pushed smaller landlords out aren't going away. The planning system that throttles new build isn't getting faster. What we're looking at is a structural floor under rental demand — and HMOs sit right at the heart of it.
SpareRoom's 27% Demand Surge — What That Actually Means for Room Rents
SpareRoom's Demand Report recorded a 27% year-on-year increase in searches for rooms in shared properties. That's not a marginal uptick — it's a cohort of renters actively shifting their behaviour because single-let affordability has collapsed beneath them.
The UK housing affordability crisis is pricing young professionals, key workers, and students out of self-contained flats in most major cities. Bill-inclusive rooms in well-managed HMOs have become the rational choice, not the fallback option. That's a meaningful shift in how tenants perceive shared living — and it directly supports the case for professionally managed HMOs over the tired student-bedsit model.
Here's the trade-off I'd name honestly: not all HMO demand is equal. Searches for rooms rising 27% nationally doesn't mean every HMO in every postcode fills overnight. Rooms in poorly located or badly managed properties still sit empty. The demand surge rewards operators who understand their tenant segment — young professionals in commuter belts, NHS workers near hospitals, contractors near industrial zones. Broad demand provides the tailwind; execution determines the yield.
Property Reporter's data puts the total number of registered HMOs in the UK at 472,823. Demand is rising against that fixed-ish stock. The maths isn't complicated.
Why Exiting Landlords Are Actually Good News for Buyers
There's a narrative doing the rounds that regulation is destroying the buy-to-let market. And for landlords who bought badly, financed expensively, or never adapted their model — yes, it is. But for investors entering now, or repositioning an existing portfolio, the regulatory pressure is doing something useful: it's clearing the market.
Landlords who can't make the numbers work under the current tax and compliance regime are selling. Some of those properties are HMOs. Some are standard buy-to-lets that could be converted. Either way, motivated sellers create buying opportunities that didn't exist when every amateur landlord was holding forever because prices only went up.
The Foot Forward research from 2026 flagged consistent tenant demand for professionally managed HMOs specifically. That word 'professionally' is doing a lot of work. The landlords exiting are largely the ones who ran their portfolios informally — the ones who didn't invest in management systems, licensing compliance, or tenant experience. Their exit creates a gap that better-capitalised, better-organised investors can fill.
I'd put it this way: the regulation that's hurting the sector is also acting as a filter. It's removing undercapitalised operators and leaving a market where prepared buyers face less competition for quality assets and inherit a tenant base that's actively searching for better options.
Finding HMOs in This Market — Why Data Matters More Than Legwork
The practical problem with HMO investing in 2026 is discovery. Unlike standard buy-to-lets, HMOs don't announce themselves on Rightmove with a badge saying 'seven-bed licensed HMO, 9.2% gross yield, Article 4 compliant.' You have to know where to look, how to identify them, and how to move fast when one surfaces.
I've seen investors spend months doing manual research — cross-referencing council licensing registers, trawling estate agent listings, cold-calling agents — only to lose deals to buyers who had better information faster. That's the gap [ZARSK](https://zarsk.co.uk/) exists to close. The database is, as far as I'm aware, the largest dedicated HMO database in the UK, and it's constantly updated. That matters in a market where speed and information asymmetry determine who gets the deal.
On the finance side, this is where I see even experienced investors trip up. Freeing equity from an existing portfolio to fund the next acquisition is genuinely difficult. Standard high-street lenders often won't touch complex HMO portfolios, and the criteria for portfolio landlords under PRA rules are strict. ZARSK's regulated finance partners have been working in this space for over a decade — they understand HMO valuations, portfolio remortgaging, and the specific structures that make equity release work in this asset class. If you're sitting on equity you can't access, that's worth a conversation. You can explore the finance options at [zarsk.co.uk/finance-property](https://www.zarsk.co.uk/finance-property).
The window is open. Supply is down. Demand is up. The landlords who couldn't adapt are leaving. What's left is a market that rewards preparation — and right now, preparation starts with having better data than the person bidding against you.
Here's what I think happens next. The regulatory pressure doesn't ease — it intensifies. The Renters' Rights Bill, energy efficiency requirements, and ongoing HMO licensing expansion will continue to push out undercapitalised landlords. Supply stays constrained. Demand from renters who can't afford self-contained flats keeps growing. And the investors who moved when the window was open — when motivated sellers were exiting, when competition was thinner, when yields were being compressed for everyone else but supported for well-run HMOs — those are the ones who'll look back at 2026 as the year they got their positioning right. The investors who waited for certainty will be reading about this window instead of having climbed through it.